Indian Regulator Tightens Drug Price-Control Loopholes
This article was originally published in PharmAsia News
Executive Summary
India's drug-pricing authority warns pharmaceutical companies they need approval before they can introduce new drugs containing ingredients that are under price controls. The National Pharmaceutical Pricing Authority changed its guidelines to tighten controls on companies using loopholes to avoid price controls. The new guidelines are intended to crack down on repeat offenders, so the second move to avoid price controls is to result in automatic prosecution, instead of waiting for several rounds of hearings and other moves before action is taken. (Click here for more